Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
The Basics of Metabolic Dysfunction-Associated Steatotic Liver Disease for Cardiologists: Pathophysiology, Diagnosis,
Muhammad Shahzeb Khan1, Syed Sarmad Javaid2, Amreen Dinani3
1Baylor Scott and White Research Institute, Dallas, Texas, USA; Department of Medicine, Baylor School of Medicine, Temple, Texas, USA; Division of Cardiology, Heart Hospital Plano, Plano, Texas, USA.
Abstract:
Metabolic dysfunction-associated steatotic liver disease (MASLD) is now recognized as a multisystem disease closely linked to cardiovascular disease, which is the leading cause of death in this population. MASLD and cardiovascular disease share overlapping pathophysiological mechanisms including insulin resistance, chronic inflammation, oxidative stress, and endothelial dysfunction that not only drive the progression of each disease but may also potentiate one another. Recent initiatives, such as the cardiovascular-kidney-metabolic health framework and the cardiovascular-renal-hepatic-metabolic model, underscore the importance of integrated, multidisciplinary care for managing multisystemic conditions like MASLD. In this context, cardiologists who frequently encounter MASLD-related comorbidities such as diabetes and obesity are well positioned to lead efforts in early detection, risk stratification, and management. This review offers cardiologists a comprehensive overview of MASLD, including the epidemiology, diagnostic approaches, and therapeutic options of MASLD while highlighting cardiologists' pivotal role in its multidisciplinary management.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Cardiomyopathy V: Interprofessional Care

